1069. Loss to follow-up does not impact SVR for HCV infection

BACKGROUND: Recent advances in hepatitis C treatment using direct acting antiviral (DAA) agents can lead to sustained virologic response (SVR) in almost all treated subjects. These data along with the availability of generic DAAs have generated optimism to eliminate HCV infection globally. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kottilil, Sita K, Kamat, Mrunal, Gupte, Amit, Shah, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777501/
http://dx.doi.org/10.1093/ofid/ofaa439.1255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777501/
http://dx.doi.org/10.1093/ofid/ofaa439.1255

Ejemplares similares